Restoring Heart Function

Developing targeted therapies to eliminate heart failure using authentic and predictive cardiac organoids.

Dynomics is not currently hiring publicly. If you respond to a public job posting or are approached by someone by other means, be wary of a potential phishing scam and report to the FTC.

heart failure

The Innovation Gap

Treatment options for heart failure are primarily symptomatic, including blood thinners, assistive devices and heart transplant. As a result, patients today face poor prognosis upon diagnosis.

We need better models to target and improve heart function.

#1

cause of death globally (CVD)

50%

5-year survival

4%

of US population

$800B

burden to healthcare system
solution

Introducing HeartDynoTM

Our approach is to engineer human cardiac organoids that function similarly to adult human heart tissue, enabling us to directly target therapeutics to the heart and its function.

We address the root causes of heart failure and restore function.

approach

Built Using Engineered Biology

Scalable

Engineered from stem cells at scale

Authentic

Mature phenotype and physiology

Predictive

Translates to clinical observation